ASTH — Astrana Health Income Statement
0.000.00%
- $2.36bn
- $2.28bn
- $1.39bn
- 84
- 38
- 71
- 69
Annual income statement for Astrana Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 561 | 687 | 774 | 1,144 | 1,387 |
Cost of Revenue | |||||
Gross Profit | 92.8 | 148 | 178 | 199 | 215 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 528 | 607 | 686 | 1,061 | 1,307 |
Operating Profit | 32.4 | 80.5 | 87.4 | 83 | 80 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.8 | 178 | 77.7 | 86.6 | 89.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17.7 | 122 | 46.1 | 45.7 | 57.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 14.1 | 37.9 | 68.9 | 45.2 | 60.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14.1 | 37.9 | 68.9 | 45.2 | 60.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.425 | 1.01 | 1.66 | 1.24 | 1.36 |